These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23110786)

  • 1. The effect of naltrexone on the perception and distress in tinnitus: an open-label pilot study.
    Vanneste S; Azevedo A; De Ridder D
    Int J Clin Pharmacol Ther; 2013 Jan; 51(1):5-11. PubMed ID: 23110786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neural correlates of tinnitus-related distress.
    Vanneste S; Plazier M; der Loo Ev; de Heyning PV; Congedo M; De Ridder D
    Neuroimage; 2010 Aug; 52(2):470-80. PubMed ID: 20417285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural correlates of tinnitus related distress: an fMRI-study.
    Golm D; Schmidt-Samoa C; Dechent P; Kröner-Herwig B
    Hear Res; 2013 Jan; 295():87-99. PubMed ID: 22445697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of alcohol as a moderator for tinnitus-related distress.
    Vanneste S; De Ridder D
    Brain Topogr; 2012 Jan; 25(1):97-105. PubMed ID: 21710223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prefrontal cortex based sex differences in tinnitus perception: same tinnitus intensity, same tinnitus distress, different mood.
    Vanneste S; Joos K; De Ridder D
    PLoS One; 2012; 7(2):e31182. PubMed ID: 22348053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified version of tinnitus retraining therapy: observing long-term outcome and predictors.
    Mazurek B; Fischer F; Haupt H; Georgiewa P; Reisshauer A; Klapp BF
    Audiol Neurootol; 2006; 11(5):276-86. PubMed ID: 16717441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients.
    Martinotti G; Di Nicola M; Romanelli R; Andreoli S; Pozzi G; Moroni N; Janiri L
    Hum Psychopharmacol; 2007 Apr; 22(3):149-56. PubMed ID: 17397097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study.
    Lubin G; Weizman A; Shmushkevitz M; Valevski A
    Hum Psychopharmacol; 2002 Jun; 17(4):181-5. PubMed ID: 12404685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
    Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
    Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone for heroin dependence treatment in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoi MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2004 Jun; 26(4):285-94. PubMed ID: 15182893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence.
    Johnson BA; Ait-Daoud N; Prihoda TJ
    Alcohol Clin Exp Res; 2000 May; 24(5):737-42. PubMed ID: 10832917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid titration and conversion in patients receiving morphine sulfate and naltrexone hydrochloride extended release capsules.
    Webster LR; Brewer R; Morris D; Cleveland JM; Setnik B
    Postgrad Med; 2011 Sep; 123(5):155-64. PubMed ID: 21904098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid antagonists in the treatment of impulse-control disorders.
    Kim SW
    J Clin Psychiatry; 1998 Apr; 59(4):159-64. PubMed ID: 9590665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of tinnitus severity by the centrally acting muscle relaxant cyclobenzaprine: an open-label pilot study.
    Coelho C; Figueiredo R; Frank E; Burger J; Schecklmann M; Landgrebe M; Langguth B; Elgoyhen AB
    Audiol Neurootol; 2012; 17(3):179-88. PubMed ID: 22302057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
    Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
    Roth AS; Ostroff RB; Hoffman RE
    J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neural network of phantom sound changes over time: a comparison between recent-onset and chronic tinnitus patients.
    Vanneste S; van de Heyning P; De Ridder D
    Eur J Neurosci; 2011 Sep; 34(5):718-31. PubMed ID: 21848924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acoustic stimulation treatments against tinnitus could be most effective when tinnitus pitch is within the stimulated frequency range.
    Schaette R; König O; Hornig D; Gross M; Kempter R
    Hear Res; 2010 Oct; 269(1-2):95-101. PubMed ID: 20619332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.